Tecentriq Archives

Home Tags Tecentriq

Prolonged Use of Immunotherapy in Alveolar Soft Part Sarcoma: Safety and...

Peter Hofland - April 18, 2026

ESMO 2025: Circulating Tumor DNA (ctDNA)–guided Treatment in Adjuvant Atezolizumab in...

Danielle Garcia - October 20, 2025

ASCO 2025: Combination of Lurbinectedin and Atezolizumab Shows Improved Survival in...

Editorial Team - May 22, 2025

Adjuvant Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection of...

Editorial Team - April 16, 2023

Rain Therapeutics and Roche to Study Milademetan + Anti-PD-L1 Immunotherapy in...

Editorial Team - January 7, 2022

Human kidney cross section. Photo courtesy: 2019 Fotolia

Cabozantinib + Atezolizumab Shows Encouraging Activity and Acceptable Tolerability in Advanced...

Editorial Team - September 21, 2021

Potential Withdrawal of Accelerated Approved Therapeutic Agents may harm Cancer Patients

Peter Hofland - May 11, 2021

Doctor talking with a patient's health in medical clinic.

Study Shows Proton Pump Inhibitors Negatively Impact Urothelial Cancer Treated with...

Editorial Team - September 28, 2020

Handling histological liver tissue sample

Atezolizumab + Bevacizumab Helps Patients Maintain Quality of Life in Colorectal...

Peter Hofland - January 27, 2020

European Society for Medical Oncology (ESMO) Asia 2019 Congress. Photo Courtesy: ESMO

Combination of Atezolizumab + Bevacizumab Improves Survival in Hepatocellular Carcinoma

Peter Hofland - November 24, 2019

12 Page 1 of 2

LATEST NEWS

Genomic Tests Guide Chemotherapy Decisions in Advanced Prostate and Breast Cancer: Landmark Evidence from...

Peter Hofland - June 30, 2026

Researchers Map Key Protein Linked to Cancer and Neurological Diseases: Structural Insights into PKCβ...

Editorial Team - June 23, 2026

CT-P72/ABP-102: A Next-Generation HER2×CD3 T-Cell Engager for Solid Tumors – Preclinical Efficacy and Therapeutic...

Editorial Team - June 23, 2026

Practice-Changing Advances in Early HER2-Positive Breast Cancer: ASCO 2026 and FDA Approvals Establish Trastuzumab...

Peter Hofland - June 23, 2026

ICAM1-high Neutrophils Promote Metastasis in Triple-Negative Breast Cancer Through Symbiotic Adhesion and Reverse Migration

Editorial Team - June 19, 2026

Press Releases | Cancer

Healthy Snack Trend Among Gen Alpha Families Drives Need for Specialized Packaging as Plexpack Delivers Equipment Solutions August 17, 2026
A growing share of parents shopping for Gen Alpha households now prioritize natural ingredients and high-protein content in snacks. This shift is driving food brands to seek packaging equipment suited to healthy snacks that preserves freshness without added preservatives. TORONTO, Aug....
Expert Radiology Named No. 602 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies August 17, 2026
San Juan-based subspecialty teleradiology practice earns a place among America's fastest-growing private companies after achieving 576% three-year revenue growth. SAN JUAN, Puerto Rico, Aug. 17, 2026 /PRNewswire-PRWeb/ -- Expert Radiology today announced it has been ranked No. 602 on the...
Knotts Family Agency Reaffirms 24/7 Parent Support Guarantee With 15-Minute Response Time for Riverside County Foster Families August 17, 2026
Knotts Family Agency has reaffirmed its 24/7 Parent Support Guarantee for foster families across Riverside County, backing the commitment with a 15-minute average response time for every after-hours call the agency receives. REDLANDS, Calif., Aug. 17, 2026 /PRNewswire-PRWeb/ -- Families...

Tag: Tecentriq

Prolonged Use of Immunotherapy in Alveolar Soft Part Sarcoma: Safety and...

ESMO 2025: Circulating Tumor DNA (ctDNA)–guided Treatment in Adjuvant Atezolizumab in...

ASCO 2025: Combination of Lurbinectedin and Atezolizumab Shows Improved Survival in...

Adjuvant Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection of...

Rain Therapeutics and Roche to Study Milademetan + Anti-PD-L1 Immunotherapy in...

Cabozantinib + Atezolizumab Shows Encouraging Activity and Acceptable Tolerability in Advanced...

Potential Withdrawal of Accelerated Approved Therapeutic Agents may harm Cancer Patients

Study Shows Proton Pump Inhibitors Negatively Impact Urothelial Cancer Treated with...

Atezolizumab + Bevacizumab Helps Patients Maintain Quality of Life in Colorectal...

Combination of Atezolizumab + Bevacizumab Improves Survival in Hepatocellular Carcinoma

LATEST NEWS

Genomic Tests Guide Chemotherapy Decisions in Advanced Prostate and Breast Cancer: Landmark Evidence from...

Researchers Map Key Protein Linked to Cancer and Neurological Diseases: Structural Insights into PKCβ...

CT-P72/ABP-102: A Next-Generation HER2×CD3 T-Cell Engager for Solid Tumors – Preclinical Efficacy and Therapeutic...

Practice-Changing Advances in Early HER2-Positive Breast Cancer: ASCO 2026 and FDA Approvals Establish Trastuzumab...

ICAM1-high Neutrophils Promote Metastasis in Triple-Negative Breast Cancer Through Symbiotic Adhesion and Reverse Migration

Genomic Tests Guide Chemotherapy Decisions in Advanced Prostate and Breast Cancer: Landmark Evidence from...

Researchers Map Key Protein Linked to Cancer and Neurological Diseases: Structural Insights into PKCβ...

CT-P72/ABP-102: A Next-Generation HER2×CD3 T-Cell Engager for Solid Tumors – Preclinical Efficacy and Therapeutic...

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...